Omada Health OMDA
$11.87 −$0.63 (-5.04%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.81 -0.51%
Open$12.29
Prev close$12.50
Day range$11.76 – $12.64
Volume1.71M
Market cap$736.39M
P/E (TTM)52.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$91.31M+34.2% YoY
Operating profit$4.82M+291.8% YoY
Net profit$6.55M+306.1% YoY
Diluted EPS$0.10+266.7% YoY
Free cash flow$13.51M+65.8% YoY
Operating cash flow$15.14M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin70.7%
Operating margin2.1%
Net margin4.2%
Return on equity5.7%
Return on assets4.4%
Return on invested capital2.8%
Current ratio4.18
Liabilities / assets21.6%
Cash & investments$243.15M
Net cash (debt)$243.15M
Free cash flow / sales6.8%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $91.31M | $87.84M | $78.05M | $260.21M | $75.85M |
| Total Operating Revenue | $91.31M | $87.84M | $78.05M | $260.21M | $75.85M |
| Cost of Revenue | $22.02M | $24.05M | $29.36M | $89.27M | $22.18M |
| Gross Profit | $69.28M | $63.79M | $48.69M | $170.94M | $53.66M |
| Operating Expense | $64.46M | $60.24M | $53.47M | $182.91M | $50.38M |
| Selling and Admin Expenses | $49.19M | $45.61M | $40.78M | $142.23M | $38.83M |
| -Selling & Marketing Expense | $29.11M | $29.89M | $26.79M | $90.04M | $24.61M |
| -General & Admin Expense | $20.08M | $15.73M | $13.99M | $52.18M | $14.22M |
| Research & Development | $15.27M | $14.63M | $12.70M | $40.68M | $11.55M |
| Operating Profit | $4.82M | $3.55M | -$4.78M | -$11.97M | $3.28M |
| Net Non-Operating Interest Income (Expense) | $1.73M | $1.75M | $1.81M | $2.77M | $1.88M |
| Non-Operating Interest Income | $1.99M | $1.76M | $1.83M | $5.31M | $1.89M |
| Non-Operating Interest Expense | $262,000.00 | $14,000.00 | $18,000.00 | $2.53M | $13,000.00 |
| Special Income (Charges) | $0.00 | – | – | -$2.11M | $0.00 |
| Pretax Profit | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Profit | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Profit from Continuing Operations | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Net Income to Parent Company | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Net Income to Common Stockholders | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Basic EPS | $0.11 | $0.09 | -$0.05 | -$0.35 | $0.09 |
| Diluted EPS | $0.10 | $0.08 | -$0.05 | -$0.35 | $0.08 |
| Other Income (Expense) | – | – | – | -$3.58M | $0.00 |
| Gain on Sale of Security | – | – | – | -$1.47M | $0.00 |
| -Less:Other Special Charges | – | – | – | $2.11M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $348.54M | $328.22M | $302.80M | $305.41M | $305.41M |
| Total Current Assets | $315.06M | $294.91M | $269.43M | $272.93M | $272.93M |
| Cash and Cash Equivalents & Short-Term Investments | $243.15M | $221.71M | $211.77M | $222.04M | $222.04M |
| -Cash and Cash Equivalents | $243.15M | $221.71M | $211.77M | $222.04M | $222.04M |
| Receivables | $48.19M | $56.57M | $39.99M | $35.22M | $35.22M |
| -Accounts Receivable | $24.62M | $31.92M | $13.60M | $13.56M | $13.56M |
| -Other Receivables | $27.00M | $26.49M | $27.85M | $22.82M | $22.82M |
| -Receivables Adjustments Allowances | -$3.42M | -$1.84M | -$1.47M | -$1.16M | -$1.16M |
| Inventory | $4.88M | $4.12M | $3.83M | $4.49M | $4.49M |
| Current Deferred Assets | $3.95M | $3.96M | $4.02M | $3.54M | $3.54M |
| Other Current Assets | $14.89M | $8.55M | $9.83M | $1.89M | $1.89M |
| Total Non-Current Assets | $33.48M | $33.31M | $33.37M | $32.47M | $32.47M |
| Net PPE | $9.74M | $9.10M | $8.46M | $7.94M | $7.94M |
| -Gross PPE | $9.74M | $9.10M | $8.46M | $19.76M | $19.76M |
| Goodwill and Other Intangible Assets | $14.34M | $14.78M | $15.22M | $15.65M | $15.65M |
| -Goodwill | $13.24M | $13.24M | $13.24M | $13.24M | $13.24M |
| -Other Intangible Assets | $1.10M | $1.54M | $1.98M | $2.41M | $2.41M |
| Non-Current Deferred Assets | $8.98M | $9.22M | $9.48M | $8.71M | $8.71M |
| Other Non-Current Assets | $417,000.00 | $215,000.00 | $226,000.00 | $165,000.00 | $165,000.00 |
| Total Liabilities | $75.38M | $75.48M | $68.68M | $75.73M | $75.73M |
| Total Current Liabilities | $75.38M | $75.48M | $68.68M | $75.73M | $75.73M |
| Payables | $8.39M | $11.80M | $8.10M | $10.28M | $10.28M |
| -Accounts Payable | $8.39M | $11.80M | $8.10M | $10.28M | $10.28M |
| Current Accrued Expenses | $41.16M | $35.98M | $31.23M | $15.85M | $15.85M |
| Current Deferred Liabilities | $25.84M | $27.70M | $29.35M | $25.06M | $25.06M |
| Total Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Equity | $273.16M | $252.74M | $234.12M | $229.68M | $229.68M |
| Stockholders' Equity | $273.16M | $252.74M | $234.12M | $229.68M | $229.68M |
| Capital Stock | $62,000.00 | $61,000.00 | $59,000.00 | $58,000.00 | $58,000.00 |
| -Common Stock | $62,000.00 | $61,000.00 | $59,000.00 | $58,000.00 | $58,000.00 |
| Additional Paid-In Capital | $720.97M | $707.10M | $693.77M | $686.37M | $686.37M |
| Retained Earnings | -$447.87M | -$454.42M | -$459.71M | -$456.74M | -$456.74M |
| Prepaid Assets | – | – | – | $5.76M | $5.76M |
| -Accumulated Depreciation | – | – | – | -$11.82M | -$11.82M |
| -Current Capital Lease Obligation | – | – | – | $0.00 | $0.00 |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
| Convertible preferred securities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $15.14M | $4.01M | -$11.83M | $18.25M | $21.38M |
| Net cash flow from continuing operations | $15.14M | $4.01M | -$11.83M | $18.25M | $21.38M |
| Net Income from Continuing Operations | $6.55M | $5.29M | -$2.97M | -$12.78M | $5.16M |
| Gain/Loss from Continuing Operations | $27,000.00 | $25,000.00 | $2,000.00 | $3.59M | $6,000.00 |
| Depreciation & Depletion & Amortization | $1.68M | $1.58M | $1.51M | $5.49M | $1.45M |
| Other Non-Cash Items | $972,000.00 | $968,000.00 | $958,000.00 | $4.07M | $872,000.00 |
| Change in Working Capital | -$1.07M | -$9.88M | -$16.35M | $3.74M | $10.45M |
| -Change in Receivables | $7.25M | -$16.97M | -$6.21M | -$12.36M | $7.16M |
| -Change in Inventory | -$761,000.00 | -$288,000.00 | $655,000.00 | -$1.19M | -$1.34M |
| -Change in Prepaid Assets | -$6.34M | $1.28M | -$1.54M | -$1.41M | $161,000.00 |
| -Change in Payables and Accrued Expense | $1.57M | $8.40M | -$11.29M | $16.84M | $7.69M |
| -Change in Other Current Assets | -$928,000.00 | -$644,000.00 | -$2.26M | -$3.26M | -$1.12M |
| -Change in Other Current Liabilities | $0.00 | $0.00 | $0.00 | -$415,000.00 | $0.00 |
| -Change In Other Working Capital | -$1.87M | -$1.65M | $4.30M | $5.53M | -$2.10M |
| Net cash flow from investing | -$1.63M | -$1.66M | -$1.56M | -$5.83M | -$1.35M |
| Net Cash Flow from Continuing Investing Activities | -$1.63M | -$1.66M | -$1.56M | -$5.83M | -$1.35M |
| Capital Expenditure | -$1.52M | -$1.52M | -$1.48M | -$4.51M | -$1.15M |
| Net PPE Purchase and Sale | -$118,000.00 | -$146,000.00 | -$78,000.00 | -$1.32M | -$199,000.00 |
| Financing Cash Flow | $7.93M | $7.60M | $3.12M | $133.22M | $3.38M |
| Net Cash Flow from Continuing Financing Activities | $7.93M | $7.60M | $3.12M | $133.22M | $3.38M |
| Net Common Stock Issuance | $0.00 | -$3.25M | $3.25M | $160.53M | $0.00 |
| Proceeds from Stock Option Exercised | $8.60M | – | – | $9.37M | $3.38M |
| Net Other Financing Charges | -$668,000.00 | -$533,000.00 | -$127,000.00 | -$5.71M | $1,000.00 |
| Ending Cash Balance | $243.15M | $221.71M | $211.77M | $222.04M | $222.04M |
| Net Change in Cash | $21.44M | $9.95M | -$10.27M | $145.64M | $23.41M |
| Beginning Cash Balance | $221.71M | $211.77M | $222.04M | $76.39M | $198.63M |
| Free Cash Flow | $13.51M | $2.34M | -$13.39M | $12.42M | $20.03M |
| Net Issuance Payments Of Debt | – | – | – | -$30.96M | $0.00 |
No comments yet — be the first to weigh in on OMDA.
Sign in to join the discussion.